Health
Study reports promising new monoclonal antibody against SARS-CoV-2’s spike protein – News-Medical.Net
An encouraging new study describes a promising new therapeutic antibody that shows potent neutralizing activity against SARS-CoV-2, the causative agent of COVID-19….
As the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), refuses to subside, the search for effective antivirals and therapeutics continues without respite. An encouraging paper published in the journal Nature Communicationson January 12, 2021, describes a promising new therapeutic antibody that potently neutralizes the virus.
SARS-CoV-2 has its own spike protein that interacts with the human angiotensin-converting enzyme 2 (ACE2)…
-
Noosa News22 hours agoJazz festival wraps up | Noosa Today
-
Noosa News17 hours agoDog owners warned: $834 fine for pets not under control
-
Noosa News19 hours agoPharmacist’s stolen image used in ‘dangerous’ deepfake adverts for weight loss drug
-
Business21 hours ago5 things to watch on the ASX 200 on Thursday 4 September 2025